Target intelligence / Profile preview

FRA10A associated CGG repeat 1 (FRA10AC1)

Target
FRA10AC1
Molecular classification
Other (nuclear phosphoprotein, gene of unknown function)
01

Overview

FRA10A associated CGG repeat 1 (FRA10AC1) encodes a nuclear phosphoprotein of unknown function in humans. The gene is notable for containing a tandem CGG repeat in its 5' untranslated region (UTR), located within a folate-sensitive fragile site on chromosome 10 (fra(10)(q23.3)). These CGG repeat tracts can normally range from 8 to 14 units, occasionally expanding to >200 repeats, leading to hypermethylation and transcriptional silencing. However, unlike other repeat expansion disorders, no direct disease phenotype has been conclusively associated with expansion of the CGG repeat in FRA10AC1. The protein product is classified as a nuclear phosphoprotein, but its precise biological role and possible involvement in pathogenesis remain unclear. The gene is sometimes referenced in the context of CGG repeat expansion research because of its similarity to other repeat loci that are implicated in neurological disorders, but it is not currently considered a druggable or therapeutic target.

Other names
C10orf4F26C11.1-likeFRA10Afragile site, folic acid type, rarefra(10)(q23.3) or fra(10)(q24.2) candidate 1FRA10A associated CGG repeat 1
02

Mechanism of action

no known mechanism as a drug target; approaches that target CGG repeat expansions involve antisense oligonucleotides, RNA interference, and small molecule binding, generally not proven for this specific locus

03

Biological functions

Unknown
04

Disease associations

Other (gene is located in a rare folate-sensitive fragile site, but expanded repeats have not been directly linked to any disease phenotype)

Beyond the preview

Go deeper on FRA10A associated CGG repeat 1 (FRA10AC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FRA10A associated CGG repeat 1 (FRA10AC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call